3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
2
Thyroid Nodule
2
Sarcoma
2
Prostatic Neoplasms
2
Melanoma
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Spinal Cord Compression
1
Precancerous Conditions
1
Papillomavirus Infections
1
Neoplasms, Unknown Primary
1
Neoplasms by Site
1
Neoplasms
1
Hyperthyroidism
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Gastrointestinal Neoplasms
1
Female Urogenital Diseases and Pregnancy Complications
1
Colorectal Cancer Metastatic
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Adenocarcinoma
1
Acquired Immunodeficiency Syndrome
1
Interventions
Bevacizumab
7
Capecitabine
4
Cetuximab
3
trifluridine tipiracil drug combination
2
Fluorouracil
2
regorafenib
1
irinotecan sucrosofate
1
folfirinox
1
balstilimab
1
Vemurafenib
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Panitumumab
1
Nivolumab
1
Liver Transplantation
1
Immune Checkpoint Inhibitors
1
HMPL-013
1
Folfox protocol
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colorectal Cancer Metastatic
×
Transurethral Resection of Prostate
×
1 year
×
Clear all
NCT05129787
2026-02-12
NEW-COMET
Oslo University Hospital
Phase NA
Active not recruiting
230 enrolled